Back
Day Range
$3.04
$3.25
52-Week Range
$1.11
$5.47
Volume
5,959,675
50D / 200D Avg
$4.17
/
$3.40
Prev Close
$3.13
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.2 | 0.3 |
| P/B | 44.5 | 3.0 |
| ROE % | -1446.0 | 3.7 |
| Net Margin % | -4436.6 | 3.8 |
| Rev Growth 5Y % | -9.2 | 10.0 |
| D/E | 4.7 | 0.2 |
Analyst Price Target
Hold
$6.00
+93.5%
Forward EPS
-$0.18
Est. Revenue
98.61M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.63
$0.49 – $0.77
|
451.33M | 1 |
| FY2028 |
$0.38
$0.30 – $0.47
|
331.11M | 1 |
| FY2027 |
$0.07
-$0.01 – $0.16
|
205.37M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-25 | -$0.08 | -$0.08 | -0.1% |
| 2025-11-13 | -$0.08 | -$0.11 | -37.5% |
| 2025-08-12 | -$0.14 | -$0.11 | +21.4% |
| 2025-05-14 | -$0.08 | -$0.07 | +12.5% |
| 2025-03-19 | -$0.06 | -$0.04 | +33.3% |
| 2024-11-14 | -$0.08 | -$0.09 | -12.5% |
| 2024-08-14 | -$0.09 | -$0.10 | -11.1% |
| 2024-05-14 | -$0.09 | -$0.10 | -11.1% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -9.23% annually over 5 years
Debt/Equity of 4.70 — high leverage
Negative free cash flow of -87.83M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 155.96%
Capital efficient — spends only 0.00% of revenue on capex
ROIC of 0.00% — low return on invested capital
Growth
Revenue Growth (5Y)
-9.23%
Revenue (1Y)146.73%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-1446.02%
ROIC0.00%
Net Margin-4436.62%
Op. Margin0.00%
Safety
Debt / Equity
4.70
Current Ratio3.09
Interest Coverage0.00
Valuation
P/E Ratio
-2.17
Forward P/EN/A
P/B Ratio44.54
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 146.73% | Revenue Growth (3Y) | 24.73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -9.23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.68M | Net Income (TTM) | -429.64M |
| ROE | -1446.02% | ROA | -276.29% |
| Gross Margin | 0.00% | Operating Margin | 0.00% |
| Net Margin | -4436.62% | Free Cash Flow (TTM) | -87.83M |
| ROIC | 0.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4.70 | Current Ratio | 3.09 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.17 | Forward P/E | N/A |
| P/B Ratio | 44.54 | P/S Ratio | 96.17 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 9.44 | Fwd Earnings Yield | N/A |
| FCF Yield | -9.43% | ||
| Market Cap | 931.33M | Enterprise Value | 999.38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.68M | 3.93M | 6.23M | 26.91M | 14.27M |
| Net Income | -429.64M | -126.24M | -95.90M | 28.32M | -92.17M |
| EPS (Diluted) | -1.37 | -0.47 | -0.39 | -0.33 | -0.47 |
| Gross Profit | 0.0 | -342,000.0 | 106,000.0 | 20.57M | -39.41M |
| Operating Income | 0.0 | -135.03M | -99.76M | -75.73M | -91.95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 155.51M | 145.27M | 151.04M | 215.98M | 359.86M |
| Total Liabilities | 134.59M | 106.75M | 32.55M | 89.72M | 252.51M |
| Shareholders' Equity | 20.91M | 38.51M | 118.50M | 126.26M | 107.35M |
| Total Debt | 98.29M | 5.50M | 7.10M | 51.42M | 190.07M |
| Cash & Equivalents | 30.23M | 29.52M | 7.58M | 4.86M | 36.42M |
| Current Assets | 115.24M | 102.41M | 68.76M | 118.16M | 156.63M |
| Current Liabilities | 37.31M | 21.52M | 22.99M | 78.65M | 34.65M |